BioSig Technologies, Inc. STEX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$506.66M-5,110% | -$462.76M-4,376% | -$39.85M-159% | -$26.18M-49.6% | -$9.72M+60.6% | ||
| $5M+3,719% | $3.53M+1,779% | $2.09M+734% | $636K+104% | $131K-63.1% | ||
| $80.4M+902% | $57.1M+715% | $8.29M-2.0% | $8.96M-32.4% | $8.02M-10.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $11.92M+377% | $8.99M+674% | -$689K-128% | ||
| —— | $96K-69.6% | $137K-61.1% | $243K-20.1% | $280K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$2.91M-251% | $196K-92.2% | $774.75K— | $1.35M— | $1.93M— | ||
| —— | -$102K+70.9% | -$145K+62.7% | -$267K+19.1% | -$308K+13.3% | ||
| $13.01M— | $1.37M— | —— | —— | —— | ||
| -$19.5M-328% | -$10.44M-119% | -$7.89M-9.2% | -$4.36M+54.5% | -$4.56M+64.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $45.36M— | —— | —— | —— | ||
| —— | $8.05M— | —— | —— | —— | ||
| —— | —— | —— | —— | $3.99M-58.4% | ||
| $48.54M+517% | $54.88M+1,065% | $18.1M+143% | $4.7M-55.1% | $7.87M-35.1% | ||
| —— | —— | —— | —— | —— | ||
| $4.04M+22.0% | $21.08M+44,019% | $11.34M+4,916% | $1.62M— | $3.31M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $80.4M+902% | $57.1M+715% | $8.29M-2.0% | $8.96M+29.1% | $8.02M+10.7% | ||
| $13.01M— | $1.37M— | —— | —— | —— | ||
| —— | -$7.02M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $389.68M— | —— | —— | —— | ||
| —— | $8.05M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $13K— | —— | —— | —— | ||
| —— | —— | —— | —— | -$95K+5.9% | ||
| —— | -$102K+70.9% | -$145K+62.7% | -$267K+19.1% | -$308K+13.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $24.47M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $8.05M— | —— | —— | —— | ||
| —— | $683K+460% | $542.75K— | $402.5K— | $262.25K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $10.48M— | —— | —— | —— | ||
| —— | $14.99M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioSig Technologies, Inc. generate?
- BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
- Where does BioSig Technologies, Inc.'s cash flow data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
